ライフサイエンスコーパス: sinus rhythm

1 rt failure with reduced ejection fraction in sinus rhythm.

2 atio, 5.43; 95% CI, 3.24-9.12) compared with sinus rhythm.

3 1 hour post procedure for the maintenance of sinus rhythm.

4 scar accurately identify VT channels during sinus rhythm.

5 emaker implantation, whereas the rest are in sinus rhythm.

6 ium, Bachmann bundle, and left atrium during sinus rhythm.

7 found in atrial appendages from patients in sinus rhythm.

8 ricular endocardial mapping was performed in sinus rhythm.

9 litude signals usually occurring late during sinus rhythm.

10 e further intervention to maintain long term sinus rhythm.

11 sired procedural end point of termination to sinus rhythm.

12 nt reduction of AF burden and maintenance of sinus rhythm.

13 et of specific treatments intended to modify sinus rhythm.

14 ed by electroanatomic voltage mapping during sinus rhythm.

15 l or chronic AF and from control subjects in sinus rhythm.

16 ac magnetic resonance images acquired during sinus rhythm.

17 to values observed among control subjects in sinus rhythm.

18 at ICU discharge, 54 patients (75%) were in sinus rhythm.

19 antiarrhythmic drug therapy for maintaining sinus rhythm.

20 with chronic AF compared with individuals in sinus rhythm.

21 larization (APD90) compared with patients in sinus rhythm.

22 oped pAF with the remaining 2289 maintaining sinus rhythm.

23 observations explained termination of AF to sinus rhythm.

24 .6+/-6.3 months, 67% of the patients were in sinus rhythm.

25 taRay catheter and Ensite NavX system during sinus rhythm.

26 nine of 49 (80%) patients remained in stable sinus rhythm.

27 paroxysmal AF when compared with patients in sinus rhythm.

28 oxyproline content compared with patients in sinus rhythm.

29 ons with a comparable rate of restoration of sinus rhythm.

30 educed left ventricular ejection fraction in sinus rhythm.

31 tion (AF) is an effective therapy to restore sinus rhythm.

32 olume index at HFpEF diagnosis compared with sinus rhythm.

33 rial fibrillation with that in patients with sinus rhythm.

34 ithout abnormal bipolar voltage (<1.5 mV) in sinus rhythm.

35 ve radiation dose than that in patients with sinus rhythm.

36 ent atrial fibrillation (AF) and controls in sinus rhythm.

37 al fibrillation (AF) in patients with normal sinus rhythm.

38 in in patients with heart failure and normal sinus rhythm.

39 n atrial ECG morphology identical to regular sinus rhythm.

40 diagnosis), concurrent AF (+/-3 months), or sinus rhythm.

41 worse cognitive performance than subjects in sinus rhythm.

42 on admission were compared with patients in sinus rhythm.

43 r for patients with heart failure who are in sinus rhythm.

44 ged QRS duration or Brugada pattern while in sinus rhythm.

45 , and superior for successful restoration of sinus rhythm.

46 ) s(-)(1); P=ns) and failed to convert AF to sinus rhythm.

47 emonstrated ventricular preexcitation during sinus rhythm.

48 tilide (1 mumol/L) failed to convert PsAF to sinus rhythm.

49 oversion was superior for the restoration of sinus rhythm.

50 al analysis of ventricular activation during sinus rhythm.

51 with better prognosis, but only for those in sinus rhythm.

52 blation may be more effective in maintaining sinus rhythm.

53 tients with left-sided heart disease-TR with sinus rhythm.

54 uires multiple procedures to maintain stable sinus rhythm.

55 equency than chloroquine and did not restore sinus rhythm (0/5).

56 patients with AF compared with patients with sinus rhythm: 10.6+/-5.5 versus 4.7+/-3.5 g, P<0.001.

57 the number of shocks required to convert to sinus rhythm (2.25+/-1.24 versus 2.41+/-1.22, P=0.31).

58 AF who underwent catheter ablation while in sinus rhythm; 20 patients were induced into AF, 20 patie

59 LGE-CMR and electroanatomic mapping (EAM) in sinus rhythm (2960 electroanatomic mapping points analyz

60 f continuous AF: 2 in patients presenting in sinus rhythm, 3 in AF lasting 1 to 3 months, 4 in AF las

61 Fractionation during sinus rhythm (5.9+/-1.8 deflections; 9.2+/-4.4-ms interv

62 itral regurgitation due to flail leaflets in sinus rhythm (65+/-13 years; median EF, 66% [60%-71%]) e

63 ion to persistent AF and without reversal to sinus rhythm; 7 sheep were euthanized after 341.3+/-16.7

64 At 1-year follow-up, 70% remained in sinus rhythm (85% out-of-antiarrhythmic drugs).

65 14 ms, P = 0.04), of AH interval during both sinus rhythm (92 +/- 13 versus 76.8 +/- 8 ms, P < 0.01)

66 < 0.0001) and in all subgroups, particularly sinus rhythm (adjusted HR: 1.25 [95% CI: 1.21 to 1.28])

67 according to AF duration: PsAF presenting in sinus rhythm (AF induced), PsAF <12 months, and PsAF >12

68 dation set AF terminated in 57%, 61% were in sinus rhythm after 4.6 years.

69 in 81% during catheter ablation, 77% were in sinus rhythm after 6 years and multiple ablations.

70 tent AF, LA voltage maps were created during sinus rhythm after circumferential pulmonary vein isolat

71 In patients with persistent AF, PVAI in sinus rhythm after direct current cardioversion is assoc

72 F: pulmonary vein antral isolation (PVAI) in sinus rhythm after direct current cardioversion versus P

73 Another 14 (9.3%) patients maintained sinus rhythm after reinitiation of antiarrhythmic drugs,

74 in sinus rhythm, only 18 (33%) converted to sinus rhythm after repeated cardioversions, whereas the

75 mpared with left-sided heart disease-TR with sinus rhythm (all P<0.05).

76 was <10 g, and if the change was >/=4.5 g in sinus rhythm and >/=8 g in atrial fibrillation (P<0.0005

77 ) were 16% (2237 of 13,945) in patients with sinus rhythm and 21% (633 of 3064) in patients with atri

78 sessed and compared between 69 patients with sinus rhythm and 25 patients with atrial fibrillation.

79 were assessed, and of these 13,946 (76%) had sinus rhythm and 3066 (17%) had atrial fibrillation at b

80 brillation alternating with short periods of sinus rhythm and 33 (40%) had refractory ventricular tac

81 ion, 914 radiofrequency applications (530 in sinus rhythm and 384 in atrial fibrillation) were analyz

82 We recruited 258 patients (209 patients in sinus rhythm and 49 with permanent atrial fibrillation)

83 rkshire swine were randomized into 2 groups (sinus rhythm and AF), and each group into 3 subgroups: s

84 ced ventricular rate by 12 beats/min in both sinus rhythm and AF.

85 n episodes alternating with short periods of sinus rhythm and age less than 50 years were independent

86 4 (1.3, 1.9) mSv, with no difference between sinus rhythm and atrial fibrillation (1.4 versus 1.5 mSv

87 e integral between applications delivered in sinus rhythm and atrial fibrillation.

88 CF and CF parameters were similar during sinus rhythm and atrial fibrillation.

89 ctivity (VNA) and IVC-IAGPNA during baseline sinus rhythm and during pacing-induced sustained AF in 6

90 Activation maps were constructed during sinus rhythm and during VT.

91 l unipolar electrograms were recorded during sinus rhythm and ectopic activation, together with pseud

92 o simulate electrical activity during normal sinus rhythm and ectopic pacing.

93 a from AF patients compared with patients in sinus rhythm and from mice infused with angiotensin II c

94 ntify the functional substrate for VT during sinus rhythm and guide targeted ablation, obviating the

95 tion from body surface potential maps during sinus rhythm and localizing endocardial and epicardial s

96 During sinus rhythm and long AV delays (>/=300 ms), 2 positive

97 ity in conduction are already present during sinus rhythm and may explain the higher vulnerability to

98 Among 4,021 obese individuals with sinus rhythm and no history of atrial fibrillation, 2,00

99 ured in human atrial tissue from patients in sinus rhythm and permanent atrial fibrillation.

100 ry vein triggers improves the maintenance of sinus rhythm and reverses disease progression.

101 ed in human atrial myocytes from patients in sinus rhythm and that its expression was significantly g

102 followed >/=1 year to assess maintenance of sinus rhythm and to monitor changes in blood pressure.

103 resence of conduction disorders in BB during sinus rhythm and to study their relation with AF.

104 surface potential maps were recorded during sinus rhythm and ventricular stimulation from 27 endocar

105 atrial appendages obtained from patients in sinus rhythm and with chronic atrial fibrillation (CAF)

106 fibrillation (defined as no plan to restore sinus rhythm) and dyspnea classified as New York Heart A

107 ythm data, 382 (17%) had AF, 1,602 (70%) had sinus rhythm, and 308 (13%) had "other" rhythm.

108 anesthetized closed-chest pigs (n=5) during sinus rhythm, and epicardial and endocardial ventricular

109 40%, New York Heart Association class II-IV, sinus rhythm, and heart rate >/=70 beats per minute) and

110 ls, vernakalant-resistant AF was reverted to sinus rhythm, and reinduction of AF by burst pacing (50

111 ecutive patients with metabolic syndrome, in sinus rhythm, and undergoing coronary artery bypass graf

112 Sinus rhythm animals had strong transgene expression but

113 During sinus rhythm, APD was shorter in LWHs compared to LANG h

114 For a total of 255 patients in sinus rhythm, apical 4- and 2-chamber views were collect

115 was discontinued, and she reverted to normal sinus rhythm approximately 2 hr later.

116 in the latest isochrone of activation during sinus rhythm are infrequently correlated with successful

117 significantly more group B patients were in sinus rhythm as compared with patients in group A (30 [5

118 The primary outcome was return to sinus rhythm at 1 min after intervention, determined by

119 The presence of sinus rhythm at 4 weeks occurred in 193 of 212 patients

120 The primary end point was the presence of sinus rhythm at 4 weeks.

121 early cardioversion in achieving a return to sinus rhythm at 4 weeks.

122 ophageal echocardiography (TEE) performed in sinus rhythm at 6 months to assess left atrial appendage

123 Her echocardiography demonstrated normal sinus rhythm at 73 beats per minute.

124 s, left atrium volume >165 mL, absent normal sinus rhythm at admission for EAM, and inducibility of a

125 oxysmal or persistent atrial fibrillation in sinus rhythm at baseline were randomly assigned in a 1:1

126 Of HFpEF patients in sinus rhythm at diagnosis, 32% developed AF over a media

127 Main exclusion criteria were absence of sinus rhythm at enrollment, cardiac transplantation, and

128 s were regular use of fish oil or absence of sinus rhythm at enrollment.

129 Efficacy in maintaining sinus rhythm at follow-up end was 60% (54%-67%).

130 mbined model of ECG and clinical parameters, sinus rhythm at long-term follow-up could be predicted w

131 redicted termination with an AUC of 0.70 and sinus rhythm at long-term follow-up with an AUC of 0.61.

132 AF history (no history of AF, AF history in sinus rhythm at surgery, and AF history in AF at surgery

133 Only 76% of patients were in normal sinus rhythm at the beginning of EAM.

134 terone Antagonist (TOPCAT) trial who were in sinus rhythm at the time of echocardiography.

135 llation episodes alternating with periods of sinus rhythm at the time of implantation had a better su

136 In 13,861 patients in sinus rhythm, beta-blockers reduced mortality versus pla

137 ssociated with atrial activation compared to sinus rhythm, but has limitations in providing specific

138 antiarrhythmic drug therapy for maintaining sinus rhythm, but its success varies depending on multip

139 d death among patients with heart failure in sinus rhythm, but raises the risk of major bleeding; and

140 discharge, the majority of patients were in sinus rhythm, but the efficacy of repetitive electrical

141 o the procedural end point of termination to sinus rhythm by elimination of subsequent ATs (P=0.004).

142 on commonly undergo immediate restoration of sinus rhythm by pharmacologic or electrical cardioversio

143 on were compared with those in patients with sinus rhythm by using the weighted mean difference metho

144 gned to standard Valsalva manoeuvre achieved sinus rhythm compared with 93 (43%) of 214 in the modifi

145 blockers in patients with heart failure and sinus rhythm compared with atrial fibrillation.

146 apping points (1409 atrial fibrillation, 556 sinus rhythm), comprising 8-s contact force (CF) and bip

147 ere measured in right atrial samples from 76 sinus rhythm (control) and 72 chronic AF (cAF) patients.

148 uration in atrial cardiomyocytes compared to sinus rhythm controls, similar to previous findings in h

149 nent atrial fibrillation than in age-matched sinus rhythm controls.

150 During the follow-up, the percentages of sinus rhythm decreased from 43% after 1 hour to 23% afte

151 o 6.2+/-0.5 Hz (P<0.01) before converting to sinus rhythm, decreased singularity point density from 0

152 py, 49 (46.7%) of those patients remained in sinus rhythm during follow-up.

153 rified atrial fibrillation before the normal sinus rhythm ECG tested by the model.

154 ncluded 180 922 patients with 649 931 normal sinus rhythm ECGs for analysis: 454 789 ECGs recorded fr

155 Artefact-free 60-second strips of normal sinus-rhythm ECGs were converted to binary strings using

156 llows identification of horses with PAF from sinus-rhythm ECGs with high accuracy.

157 by complexity analysis of apparently normal sinus-rhythm ECGs.

158 All 19 patients underwent 2 detailed sinus rhythm electroanatomic endocardial voltage maps (a

159 nsional electroanatomic maps acquired during sinus rhythm (endocardium, 509+/-291 points/map; epicard

160 All parents were asymptomatic and in sinus rhythm, except for 1 with undetected complete AV b

161 ricular tachycardia re-entry circuits during sinus rhythm focuses on sites with abnormal electrograms

162 Seven sham-operated animals were in sinus rhythm for 1 year.

163 tic resonance imaging volumetric data during sinus rhythm for all patients.

164 VT and sinus rhythm fractionation sites were adjacent to LBs ap

165 Risk in Communities (ARIC) study who were in sinus rhythm, free of valvular disease, and had acceptab

166 n=675; mean age, 71+/-9 years; 60% women) in sinus rhythm from the population-based Northern Manhatta

167 and posterior wall/septum ablation while in sinus rhythm (group 1), versus same ablation in group 1

168 A) or further ablation of subsequent ATs to sinus rhythm (group B).

169 Patients maintaining sinus rhythm had a lesser decline in DE between acute an

170 in for patients with heart failure in normal sinus rhythm has not been definitively established.

171 orithm applied to electrocardiography during sinus rhythm has recently been shown to detect concurren

172 tion in all-cause mortality in patients with sinus rhythm (hazard ratio 0.73, 0.67-0.80; p<0.001), bu

173 erval, 3.03-35.0) or AH(SVT)<AH(NSR) (normal sinus rhythm) His-refractory ventricular premature depol

174 d with better prognosis only for patients in sinus rhythm (HR: 1.16 per 10 beats/min increase, 95% CI

175 lectrical cardioversion immediately restored sinus rhythm in 102 sessions (71%).

176 ial activation mapping were performed during sinus rhythm in 22 patients before pulmonary vein isolat

177 Atropine restored sinus rhythm in 5 of 5 Ex rats with AF sustained >15 min

178 /-32 beats per minute, P<0.001, and restored sinus rhythm in 7/7 dogs.

179 ents was immediately successful in restoring sinus rhythm in 71% of sessions.

180 DCCV restored sinus rhythm in all patients.

181 Conventional mapping was performed in sinus rhythm in all, and a high-density Pentaray mapping

182 Catheter ablation is effective in restoring sinus rhythm in atrial fibrillation (AF), but its effect

183 e and increasingly used approach to maintain sinus rhythm in atrial fibrillation patients, with promi

184 d second-line therapy for the maintenance of sinus rhythm in atrial fibrillation.

185 ity of I(Kur) as a target for maintenance of sinus rhythm in patients with a history of atrial fibril

186 e most frequently used agent for maintaining sinus rhythm in patients with AF, but it impairs the sin

187 ore effective than drug therapy in restoring sinus rhythm in patients with atrial fibrillation (AF),

188 ation (ie, cardioversion) and maintenance of sinus rhythm in patients with atrial fibrillation are re

189 r pharmacological therapy for maintenance of sinus rhythm in patients with both paroxysmal and persis

190 Restoring sinus rhythm in patients with heart failure (HF) and atr

191 sess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation [FORWARD]

192 Catheter ablation is effective in restoring sinus rhythm in selected patients with persistent AF and

193 ntricular tachycardia, sinus bradycardia and sinus rhythm including sinus irregularity rhythm.

194 In patients with heart failure in sinus rhythm, increasing TTR is associated with better o

195 During sinus rhythm intramural late potentials tended to be mor

196 Catheter ablation to restore and maintain sinus rhythm is a modality that promises to be advantage

197 However, whether immediate restoration of sinus rhythm is necessary is not known, since atrial fib

198 Sinus rhythm is often needed to control symptoms; howeve

199 oke can occur in patients with AF even after sinus rhythm is restored.

200 ion are another group in whom maintenance of sinus rhythm is thought to be advantageous.

201 prolonged QT diagnostic statement (assuming sinus rhythm <100 beats per minute and QRS duration <120

202 For a similar sinus rhythm maintenance at 12 months (90% versus 88%; P

203 rall, 21+/-4 months after 1 PVI session, the sinus rhythm maintenance rate without antiarrhythmic dru

204 dergo PVI and leads to a substantial midterm sinus rhythm maintenance rate.

205 ial benefits of risk factor modification for sinus rhythm maintenance.

206 the presence of spectral AP alternans during sinus rhythm may obviate the need to actually demonstrat

207 rial fibrillation were older than those with sinus rhythm (mean age +/- standard deviation, 68 years

208 greater all-cause mortality for patients in sinus rhythm (n = 14,166; adjusted HR: 1.11 per 10 beats

209 AT (n = 1), atrial fibrillation (n = 1), or sinus rhythm (n = 2) during the electrophysiological pro

210 atrial fibrillation (n = 158) and those with sinus rhythm (n = 416).

211 an atrial myocytes obtained from patients in sinus rhythm, nNOS inhibition was sufficient to recapitu

212 the early-cardioversion group, conversion to sinus rhythm occurred spontaneously before the initiatio

213 n episodes alternating with short periods of sinus rhythm (odds ratio, 0.18; 95% CI, 0.06-0.52; p = 0

214 At 5 years, 73% were in sinus rhythm off antiarrhythmic medications after single

215 Those with sinus rhythm on 12-lead ECG, no history of AF, and >/=2

216 ibrillation the first day were reported with sinus rhythm on day 2.

217 1% underwent cardioversion, and 92% were in sinus rhythm on discharge.

218 icular hypertrophy with no history of AF, in sinus rhythm on their baseline electrocardiogram, random

219 Of the 54 patients in sinus rhythm, only 18 (33%) converted to sinus rhythm af

220 either had a propagation sequence similar to sinus rhythm or arose near papillary muscles, and (2) st

221 ure with reduced ejection fraction in either sinus rhythm or atrial fibrillation (AF).

222 The presence of sinus rhythm or atrial fibrillation was ascertained from

223 and excellent image quality in patients with sinus rhythm or atrial fibrillation.

224 FIRM ablation terminated AF to sinus rhythm or atrial flutter or tachycardia in 59% (PA

225 am mapping was performed pre-ablation during sinus rhythm or LA pacing, and electrogram locations wer

226 r sequential movement of ripple bars, during sinus rhythm or pacing, which were distinct from surroun

227 ith rheumatic mitral valve disease in either sinus rhythm or persistent AF were analyzed using a comb

228 ation of tachycardia with the restoration of sinus rhythm or suppression of the tachycardia to <100 b

229 lectrograms were collected using CARTO3v4 in sinus rhythm or ventricular pacing and reviewed for ripp

230 (86.1%), AF acutely terminated (n=20; 16 to sinus rhythm) or organized (n=11; 19+/-8% slowing) with

231 ted to display ventricular activation during sinus rhythm over 8 isochrones.

232 have persistent forms of AF and had a lower sinus rhythm P-wave amplitude.

233 35.7% higher, respectively, than patients in sinus rhythm (p < 0.05).

234 atria of chronic AF patients (by 54% versus sinus rhythm; p<0.05).

235 ial JPH2 levels per RyR2 channel compared to sinus rhythm patients and an increased frequency of spon

236 Right-atrial appendages from control sinus rhythm patients or patients with pAF (last episode

237 In sinus rhythm patients undergoing cardiac surgery, histop

238 An AI-enabled ECG acquired during normal sinus rhythm permits identification at point of care of

239 le with atrial fibrillation (AF), periods of sinus rhythm present an opportunity to detect prothrombo

240 Mortality was lower for patients in sinus rhythm randomized to beta-blockers (HR: 0.73 vs. p

241 r it can convert atrial fibrillation (AF) to sinus rhythm remains unclear.

242 us 3.7% (2.9%-4.5%) in patients with pAF and sinus rhythm, respectively.

243 Stable sinus rhythm restoration was immediate in 61.5% of patie

244 Electrocardiography showed sinus rhythm, right bundle branch block, T-wave inversio

245 Six horses were evaluated during sinus rhythm, right ventricular pacing without preceding

246 left ventricular ejection fraction <50% and sinus rhythm should receive beta-blocker therapy even wi

247 ents with atrial fibrillation and those with sinus rhythm showed no difference in heart rate (P = .16

248 months, 88% of ablation patients maintained sinus rhythm (single-procedure success 68%).

249 el omnipolar peak-to-peak voltages (Vmax) in sinus rhythm (SR) and AF.

250 A total of 1262 patients manifested sinus rhythm (SR) at baseline/SR at discharge, 113 SR ba

251 pacity among patients with HFpEF who were in sinus rhythm (SR) or AF.

252 bclinical cardiomyopathy that persists after sinus rhythm (SR) restoration, providing a substrate for

253 superimposed on an AFL substrate (AF+AFLs); sinus rhythm (SR) with an AFL substrate (SR+AFLs; contro

254 +/- 10%), 1,646 presented at diagnosis with sinus rhythm (SR), 317 with paroxysmal AD, and 462 with

255 mias in atrial trabeculae from patients with sinus rhythm (SR), but whether these arrhythmias occur i

256 compromised compared to patients with PH and sinus rhythm (SR).

257 n characterized by activation slowing during sinus rhythm (SR).

258 results with those obtained in patients with sinus rhythm (SR).

259 ony, which also occurs to some degree during sinus rhythm (SR).

260 s or older with at least one digital, normal sinus rhythm, standard 10-second, 12-lead ECG acquired i

261 shortening to maintain values observed among sinus rhythm subjects.

262 Among patients with reduced LVEF who were in sinus rhythm, there was no significant overall differenc

263 nduced activation from 228.4+/-7.6 ms during sinus rhythm to 328.3+/-6.2 ms during cardiac memory.

264 roanatomical voltage map was obtained during sinus rhythm to define scar areas (<1.5 mV) and CCs insi

265 ts with no AF (mean age, 54 years +/- 16) in sinus rhythm to establish control values and convert the

266 ular rate control and require restoration of sinus rhythm to improve their quality of life.

267 s significantly increased from patients with sinus rhythm to paroxysmal AF and persistent AF, respect

268 inical outcomes in heart failure patients in sinus rhythm treated with warfarin.

269 followed for 1 year to assess maintenance of sinus rhythm using an implantable loop recorder.

270 of atrial fibrillation present during normal sinus rhythm using standard 10-second, 12-lead ECGs.

271 ential durations in atrial cardiomyocytes to sinus rhythm values.

272 Absolute timing difference for sinus rhythm was 10+/-5 and 11+/-8 ms respectively, and

273 s during VT and substrate abnormality during sinus rhythm was also investigated.

274 A higher proportion of time spent in sinus rhythm was associated with a greater improvement i

275 owever, a higher proportion of time spent in sinus rhythm was associated with a modestly greater impr

276 By contrast, sinus rhythm was associated with beneficial effects on N

277 titive electrical cardioversion in restoring sinus rhythm was disappointing.

278 Although the success rate of restoring sinus rhythm was high, tachyarrhythmias and bradyarrhyth

279 Stable sinus rhythm was maintained in 32 patients (64%) of the

280 After multiple procedures, sinus rhythm was maintained in 91 of 202 (45.0%) patient

281 Acute conversion to sinus rhythm was observed in 2 patients after ablation o

282 lectrodes, interelectrode distance: 2 mm) of sinus rhythm was performed in 185 patients during corona

283 Sinus rhythm was recorded on 12-lead electrocardiograms

284 d consistent RA-left atrium activation until sinus rhythm was restored.

285 culated activation for the in situ hearts in sinus rhythm was similar to patterns recorded in Langend

286 Conversion of atrial arrhythmia to sinus rhythm was the primary efficacy end point.

287 bnormal ventricular activities (LAVA) during sinus rhythm were assessed with regard to the WT.

288 Pre-operative and intraoperative sinus rhythm were associated with improved survival.

289 Atrial ectopics during sinus rhythm were observed more frequently when CF was >

290 We randomly assigned 1922 patients in sinus rhythm who were scheduled for elective cardiac sur

291 thirty consecutive patients of either sex in sinus rhythm, who were admitted to the medical emergency

292 The restoration of sinus rhythm with CA results in significant improvements

293 Maintenance of sinus rhythm with drugs or catheter ablation should be c

294 disease-related AF) and from 39 patients in sinus rhythm with mitral valve regurgitation (group 2; 3

295 s a substantial evidence base in patients in sinus rhythm with significant systolic dysfunction, symp

296 ysis Program (GE Healthcare), and exhibiting sinus rhythms with heart rate <100 beats per minute and

297 with atrial fibrillation than in those with sinus rhythm, with a mean difference of 4.03 mSv (95% CI

298 e delayed-cardioversion group, conversion to sinus rhythm within 48 hours occurred spontaneously in 1

299 dure, 97 of 150 (64.7%) patients remained in sinus rhythm without antiarrhythmic drugs.

300 Whether prompt restoration of sinus rhythm would improve outcomes in patients hospital